Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 3:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 2,512 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Health Care Quality, Access, and Evaluation, Delivery of Health Care, Immune System Diseases, HIV Infections
Interventions: Rates of HIV testing and receipt of results, Sexual risk reduction; HIV knowledge improvement; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 251 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: West Los Angeles, California

Conditions: Scar
Interventions: 5-0 Polypropylene epidermal suture, 5-0 Fast gut epidermal suture; Device
Lead sponsor: Melissa Pugliano-Mauro; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania

Conditions: Intervention-carbon Monoxide Alarm + Educational Tool, Control- Usual Care Flyer on Carbon Monoxide
Interventions: Educational Tool & Carbon Monoxide Alarm; Behavioral
Lead sponsor: Lara McKenzie; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection, Upper Respiratory Tract Infection, Upper Respiratory Disease
Interventions: Novavax COVID-19 vaccine (2023-2024 formula XBB containing), Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing); Biological
Lead sponsor: Sarang K. Yoon, DO, MOH; Other
Eligibility: 18 Years and older
Enrollment: 1,188 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Multiple Sclerosis
Interventions: Active-Alert Hypnosis, Traditional Hypnosis; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: COVID-19, Children With Medical Complexity (CMC)
Interventions: BinaxNOW Rapid Antigen System; Diagnostic Test
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Ultrasound, Education, Virtual
Interventions: Butterfly handheld ultrasound machine; Combination Product
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Abdominal Aortic Aneurysm (AAA)
Interventions: Assess AAA rupture risk by PET-CTA scans, 18F-fludeoxyglucose (FDG), 11C-PBR28; Drug · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 45 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Depression, Major Depressive Disorder
Interventions: Naltrexone 50 Mg Oral Tablet, Placebo oral tablet; Drug
Lead sponsor: Marta Peciña, MD PhD; Other
Eligibility: 18 Years to 55 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Acute Coronary Syndrome
Interventions: Triage CardioProfilER (Troponin I, Myoglobin, CK-MB, BNP); Device
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 6
States / cities: Sacramento, California • Detroit, Michigan • Charlotte, North Carolina + 3 more

Conditions: Obesity
Interventions: CX11, Placebo; Drug · Other
Lead sponsor: Corxel Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 17
States / cities: Phoenix, Arizona • Inglewood, California • San Diego, California + 13 more

Conditions: Heart Failure, Dyspnea
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 375 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Appendicitis, Evidence of Cholecystectomy, Gallstones, Pregnancy, Ectopic, Aortic Aneurysm, Kidney Stones, Intrauterine Pregnancy, Diverticulitis, Abdominal Injuries, Tumors, Pancreatitis, Digestive System Diseases, Gastrointestinal Diseases, Intraabdominal Infections, Intestinal Diseases, Pregnancy, Vascular Disease, Uterine Fibroids, Ovarian Cysts, Uterine Abnominalies, Bladder Abnominalies, Testicular Abnominalies, Polyps
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Bacterial Vaginosis, Urogenital Infection by Trichomonas Vaginalis
Interventions: OSOM Trichomonas Rapid Test, OSOM BVBlue Test; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 15 Years and older · Female only
Enrollment: 519 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Diabetes Mellitus
Interventions: Regular Human Insulin, Lispro, VIAject, VIAject 50%, VIAject/Insulin Glargine, Insulin Glargine/VIAject; Drug
Lead sponsor: Biodel; Industry
Eligibility: 19 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Chula Vista, California

Conditions: Metastatic Bone Lesion
Interventions: Stereotactic Body Radiation Therapy; Radiation
Lead sponsor: Paul W. Read, MD; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: HIV/AIDS
Interventions: POC, Ag/Ab, POC + Ag/Ab; Diagnostic Test
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 6,613 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diseases/Diagnoses, Genetic Disease
Interventions: Rapid whole genome sequencing (StatSeq); Other
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: Up to 4 Months
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Sexual Violence
Interventions: Youth VIP; Behavioral
Lead sponsor: University of New Hampshire; Other
Eligibility: 12 Years to 90 Years
Enrollment: 2,647 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, New Hampshire

Conditions: Blood Pressure Control
Interventions: ACT-BP Intervention; Other
Lead sponsor: Elizabeth Pfoh; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Cleveland, Ohio • Mayfield Heights, Ohio

Conditions: Depression - Major Depressive Disorder
Interventions: intermittent theta burst stimulation, Sham (No Treatment); Device
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 65 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Diffuse Apneic Oxygenation
Interventions: Oxygen, Standard of care; Other
Lead sponsor: New York City Health and Hospitals Corporation; Other
Eligibility: 18 Years and older
Enrollment: 206 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Diabetes, Obesity
Interventions: Pre-study dietary and exercise instruction., Screening examination and oral glucose tolerance test, Euglycemic clamp, VO2max., Acute exercise bout, Percutaneous needle muscle biopsies; Behavioral · Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 59 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Type 1 Diabetes Mellitus
Interventions: Commercial Hylenex® recombinant (hyaluronidase human injection), Precommercial Hylenex recombinant (hyaluronidase human injection), Insulin lispro, Insulin aspart, Insulin glulisine; Drug
Lead sponsor: Halozyme Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 39
States / cities: Concord, California • Encino, California • Escondido, California + 35 more

Search by objective public record fields.

Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling

Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color

Emergency Department Brief Intervention to Increase Carbon Monoxide Detector Use

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Waking Hypnosis in the Treatment of MS-related Fatigue

ReSET Aim 1a: Restarting Safe Education and Testing for Children With Medical Complexity - Feasibility of In-home Cohort COVID-19 Testing Strategies, and Associations With CMC Parent Perceptions About In-person School Attendance

Tele-Ultrasound: VIrtual Hands-on Education for Novice Users

Predictors of AAA Expansion and/or Rupture

Study of Naltrexone-Induced Blockade of Antidepressant Effects

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants

Bedside Ultrasound Identifies Congestive Heart Failure

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

A Validation Study of Genzyme Diagnostics OSOM Trichomonas Rapid Test and BVBlue Test

A Study Comparing the Pharmacodynamic Properties of Insulin VIAJECT™, Regular Human Insulin, and Insulin Lispro

Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow

HIV Jail POC-AgAB Testings

Genomic Sequencing in Acutely Ill Neonates

Preventing Sexual Violence Through a Comprehensive, Peer-led Initiative

Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes

Sham-Controlled Rapid-Acting Neuromodulation for Depression

EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation

PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)